Abstracts
The Epstein-Barr virus (EBV) is a well-known example of a human virus which interacts most intimately with the immune system. EBV is a polyclonal B lymphocyte activator, can immortalize B cells and, depending on situations, can also induce different T cell and cytokine activities (1–6). The present paper examines briefly several immunoregulatory aspects of EBV interaction with the immune system, many of which are pertinent to our understanding of immune controls over EBV infections. Various effects of EBV infection on cells of the immune system and their products are thus examined.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
A. Rosen et al. Nature 267, 52 (1977).
P.J. Sheldon et al. Lancet 1, 1153 (1973).
P.K. Pattengale et al. J. Nat. Cancer Inst. 52, 1081 (1974).
J. Menezes et al. Infection and Immunity 13, 303 (1975).
J. Menezes et al. In “Viral Mechanisms of Immuno-suppression”, Progr. Leukocyte Biology 1, 115 (1985.).
G. Tosato, Adv. Cancer Res. 49, 75 (1987).
W. Henle et al. Science 157, 1064 (1967).
J.H. Pope et al. Int. J. Cancer 3, 867 (1968).
A.C. Bird and S. Britton. Immunol. Rev. 45, 41 (1979).
H. Kubagawa et al. In “Current Topics in Microbiology and Immunology”, Springer-Verlag, Berlin, 132, 246 (1986).
G. Henle and W. Henle. In “The Epstein-Barr virus” (M.A. Epstein, B.G. Achong, Eds.), Sping-Verlag, Berlin, 297 (1979).
P.K. Lai et al. Nature 252, 608 (1974).
W.H. Wainwright et al. J. Infect. Dis. 140, 22 (1979).
R.W. Veltri et al. J. Immunol 127, 320 (1981).
S.K. Sundar et al. Int. J. Immunopharmacol. 9, 869 (1987).
S.K. Sundar and J. Menezes. Int. J. Immunopharmacol. 8, 101 (1986).
S. Fong et al. J. Immunol. 126, 910 (1981).
C. Garzelli et al. J. Virol. 52, 722 (1984).
G.P. Allaway et al. J. Infect. Dis. 157 (5), 968 (1988).
V.D. Mottironi and P.I. Terasaki. In “Histocompatibility Testing” (P.I. Terasaki. Ed.), Copenhegan, Munskeard, pp. 301–307 (1970).
P. Andersson, Acta. Pathol. Microbiol. Immunol. Scand, 83, 19 (1975)
B.A. Blazar et al. Cancer Res. 43, 4562 (1983).
J. Gordon et al. Nature 310, 145 (1984).
G. Scala et al. J. Exp. Med. 159, 1637 (1984).
B.A. Blazar et al. Cancer Immunol. Immunother. 22, 62 (1986).
H. Wakasugi et al. Proc. Natl. Acad. Sci. USA 84, 804 (1987).
S.K. Sundar et al. Clin. Exp. Immunol. 56, 701 (1984).
M. Lotz et al. J. Immunol. 136, 3643 (1986).
M. Jondal and G. Klein. J. Exp. Med. 138, 1365 (1973).
G. Sauvageau et al. In “Epstein-Barr Virus and Human Disease”, (P.H. Levine, D.V. Ablashi et al. Eds.), Humana Press, Clifton, N.J., pp. 389–392 (1987).
E.L. Reinhertz et al. J. Immunol. 125, 1269 (1980).
B.F. Haynes et al. J. Immunol. 123, 2095 (1979).
H.E. Johnsen et al. Scand. J. Immunol. 10, 251 (1979).
G. Tosato et al. N. Eng. J. Med. 301, 1133 (1979).
S.K. Sundar and J. Menezes. Int. J. Cancer 35, 351 (1985).
S.K. Sundar and J. Menezes. Microbial. Pathogenesis, 2, 259 (1987).
T. Tursz et al. Nature 269, 806 (1977).
M. Lipinski et al. J. Exp. Med. 150, 1310 (1979).
E. Klein et al. In “Cold Spring Harbor Conf. Cell Prolif. 7, 1187 (1980).
P.C. Patel et al. Infection and Immunity 38, 251 (1982).
A. Ducantenzeiler and J. Menezes. Int. J. Immunopharmacol. 10, 81 (1988).
S.K. Sundar et al. Int. J. Cancer 29, 407 (1982).
F.K. Mathew et al. J. Cancer 27, 175 (1981).
E. Svedmyr et al. Clin. Immunol. Immunopathol. 30, 437 (1984).
E. Svedmyr and M. Jondal. Proc. Nat. Acad. Sci. 72, 1622 (1975).
I.S. Misko et al. Proc. Nat. Acad. Sci. 77, 4729 (1980).
A. B. Rickinson et al. Nature 283, 865 (1980).
D. J. Moss et al. Eur. J. Immunol. 11, 686 (1981).
L. E. Wallace et al. Eur. J. Immunol. 12, 1012 (1982)
S.C. Meurer et al. J. Immunol, 131, 186 (1983).
I.S. Misko et al. Int. J. Cancer, 33 239 (1984).
I. S. Misko et al. In “Epstein-Barr Virus and Human Disease”, (P.H. Levine, D.V. Ablashi et al. Eds), Humana Press, Clifton, New Jersey, pp. 343–347 (1987).
B.M. Carreno et al. J. Exp. Clinical Cancer Res. 7, 99 (1988 - Supplement).
M. Lotz et al. Eur. J. Immunol. 15, 120 (1985).
D.A. Thorley-Lawson. J. Immunol. 126, 829 (1981).
M. Andersson et al. Eur. J. Immunol. 13, 6 (1983).
F. Hasler et al. J. Exp. Med. 157, 173 (1983).
T. C. Shope and J. Kaplan. J. Immunol. 123, 2150 (1979).
P.A. Bardwich et al. Arthritis Reum. 23, 626 (1980).
M.G. Masucci et al. Cell. Immunol. 76, 311 (1983).
F. Wang et al. Clin. Res. 33, 391 (1985).
J. Menezes et al. Nature, 260, 430 (1976).
S. Kohl et al. J. Pediatr. 112, 976 (1988).
J. Gosselin et al. (submitted for publication)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 The Humana Press Inc.
About this chapter
Cite this chapter
Menezes, J., Gosselin, J., Kundu, S. (1989). Epstein-Barr Virus Infection and Immunoregulation. In: Ablashi, D.V., Faggioni, A., Krueger, G.R.F., Pagano, J.S., Pearson, G.R. (eds) Epstein-Barr Virus and Human Disease • 1988. Experimental Biology and Medicine, vol 20. Humana Press. https://doi.org/10.1007/978-1-4612-4508-7_26
Download citation
DOI: https://doi.org/10.1007/978-1-4612-4508-7_26
Publisher Name: Humana Press
Print ISBN: 978-1-4612-8852-7
Online ISBN: 978-1-4612-4508-7
eBook Packages: Springer Book Archive